Super "big group buy" these 17 drugs are expected to drop in price
Recently, the "Announcement of the Medical Security Bureau of Sichuan and other 8 provinces and autonomous regions on the development of centralized drug procurement in the inter-provincial alliance" (hereinafter referred to as the "Announcement") was officially released.
Eight provinces (regions) including Sichuan, Shanxi, Inner Mongolia, Liaoning, Jilin, Heilongjiang, Hainan, and Tibet, as an inter-provincial alliance, carry out centralized drug procurement with the goal of "promoting drug prices back to a reasonable level and further reducing the burden of drug use by the masses" .
Provincial Medical Insurance Bureau lead organization
17 kinds of drugs are included in the volume procurement
The Chengdu Business Daily-Red Star News reporter learned that this inter-provincial alliance concentrated procurement, led by the Sichuan Provincial Medical Insurance Bureau, and included a total of 17 drugs for procurement, including drugs commonly used for many common diseases.
In other words, these 17 drugs will usher in the "super group purchase" of the inter-provincial alliance in the future, which is expected to reduce the burden on patients at a lower price.
The 17 drugs included in the centralized drug purchase list include troxerutin injection, citicoline injection, compound glycyrrhizin (compound glycyrrhizin) oral regular-release dosage form, compound diisopropylamine dichloroacetate (two Diisopropylamine gluconate sodium chloroacetate) injection, papaverine injection, aescin injection, niacin injection, oral calcium acetate oral dosage form, phloroglucinol injection, lipoic acid injection, ursodeoxycholic acid oral oral dosage form , Adenosine Methionine Injection, Lansoprazole Injection, Ranitidine Injection, Midazolam Injection, Methylprednisolone Injection, and Meglumine Cyclophosphate Injection.
The reporter learned that these drugs are commonly used and common drugs.
For example, troxerutin injection is a relatively common injection for the treatment of thrombophlebitis; lipoic acid injection is often used for diabetic complications.
According to the "Announcement", the scope of implementation of this procurement includes public medical institutions and military medical institutions in 8 provinces (regions) including Sichuan.
Other medical institutions are implemented in accordance with the regulations of the provinces (regions) of the Union.
Some expensive and commonly used drugs
Is expected to usher in a substantial price cut
The so-called "purchasing with quantity" refers to the clarification of the quantity of purchases when bidding or negotiation and bargaining are carried out in the process of centralized drug purchase, so that the company can quote the specific quantity of drugs.
In the past drug bidding and procurement, generally only the price is not included, so companies lack sales expectations and it is difficult to achieve a significant drop in drug prices.
Regardless of whether it is national centralized procurement or inter-provincial alliance centralized procurement, it is like "group buying", which combines the amount into a large procurement package and promises the purchase amount.
This also guarantees the sales volume of the winning bidders, saves a lot of circulation and marketing costs, and thus has a large room for price reduction.
Since the pilot implementation of centralized drug procurement organized by the state in December 2018, the number of purchased drugs has reached more than 100, and each centralized procurement has caused some high-priced but large-volume drugs to be significantly reduced in price.
In early May of this year, Sichuan Provincial People’s Hospital, the First Affiliated Hospital of Chengdu Medical College, and Chengdu University of Traditional Chinese Medicine and other provincial-managed public hospitals successively issued the second batch of the first (second) prescription or first prescription or Medical advice.
The second batch of national organizations in Sichuan Province centrally purchased 47 drugs in 32 types, mainly involving antipyretic and analgesic, antibacterial and anti-inflammatory, anti-allergic, anti-tuberculosis, chemotherapy and other therapeutic areas, covering chronic diseases such as hypertension, diabetes, tumors, and major diseases. For diseases and rare diseases, the average price reduction of selected drugs reached 53%, and the highest reduction reached 93%.
In fact, just a month and a half ago, the third largest group of countries so far organized the results of the selection of centralized drug procurement. A total of 55 drugs were selected from 191 brand products, with an average price reduction of 53%.